This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Complications

Authoring team

Conditions associated with transplantation and immunosuppression:

  • acute and chronic rejection
    • acute rejection - this occurs 3-6 months after transplantation; features include rising serum creatinine (also occasionally graft pain and fever); graft biopsy reveals tubular damage and an immune cell infiltrate; treatment options include high-dose corticosteroids
    • chronic rejection - occurs >6 months after transplantation; gradual increase in serum creatinine and proteinuria. Graft biopsy reveals fibrosis, vascular changes and tubular atrophy. Chronic rejection is not responsive to increased immunosuppression
  • acute tubular necrosis
  • thrombosis
  • opportunistic infections
  • hypertension - occurs in more than 50% of transplant patients; causes include diseased native kidneys, graft dysfunction or immunosuppressant drugs
  • cyclosporin toxicity
  • increased risk of malignancy - particularly, lymphoproliferative disorders such as non-Hodgkin's lymphoma and squamous-cell skin carcinoma

Conditions that can recur in the transplanted kidney:

  • mesangiocapillary glomerulonephritis
  • focal segmental sclerosis
  • IgA nephropathy
  • Goodpasture's syndrome
  • vasculitides

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.